Dare Bioscience
DARE
25 hedge funds and large institutions have $2.43M invested in Dare Bioscience in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
17% more capital invested
Capital invested by funds: $2.08M → $2.43M (+$345K)
14% more funds holding
Funds holding: 22 → 25 (+3)
1.27% more ownership
Funds ownership: 7.67% → 8.93% (+1.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AE
AMH Equity
Great Neck,
New York
|
+$173K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$141K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$109K |
| 4 |
Jane Street
New York
|
+$57.5K |
| 5 |
Renaissance Technologies
New York
|
+$14.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FFS
Founders Financial Securities
Towson,
Maryland
|
-$37.5K |
| 2 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$5.04K |
| 3 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$2.95K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$1.7K |
| 5 |
WSFS
Wilmington Savings Fund Society
Wilmington,
Delaware
|
-$230 |
DARE Hedge Fund Activity: Q4 2024 in Review
25 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q4 2024, worth a combined $2.43M — up 17% from $2.08M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new DARE positions and 3 closed out — a net gain of 4 holders — while 6 added to existing stakes and 2 trimmed.
The largest buyer was AMH Equity, adding an estimated $173K. The largest seller was Founders Financial Securities, exiting entirely with an estimated $37.5K sold.
- 25 institutional investors held Dare Bioscience (DARE) as of Q4 2024, up from 22 in Q3 2024.
- Funds reported $2.43M of Dare Bioscience stock for Q4 2024, up 17% quarter-over-quarter.
- 7 funds opened new Dare Bioscience positions in Q4 2024 and 3 closed out, a net change of +4 holders.
- The largest Dare Bioscience buyer in Q4 2024 was AMH Equity, an estimated $173K added.
- The largest Dare Bioscience seller in Q4 2024 was Founders Financial Securities, an estimated $37.5K sold.
Based on aggregated 13F filings for Q4 2024.